Analysts expect CRISPR Therapeutics AG (NASDAQ:CRSP) to report $-0.74 EPS on March, 9.They anticipate $0.34 EPS change or 85.00% from last quarter’s $-0.4 EPS. After having $-0.62 EPS previously, CRISPR Therapeutics AG’s analysts see 19.35% EPS growth. The stock increased 2.17% or $0.88 during the last trading session, reaching $41.5. About 244,599 shares traded. CRISPR Therapeutics AG (NASDAQ:CRSP) has 0.00% since February 16, 2017 and is . It has underperformed by 16.70% the S&P500.
Cohen & Steers Inc increased Newmont Mining Corporation (NEM) stake by 53.41% reported in 2017Q3 SEC filing. Cohen & Steers Inc acquired 37,813 shares as Newmont Mining Corporation (NEM)’s stock declined 9.13%. The Cohen & Steers Inc holds 108,616 shares with $4.07 million value, up from 70,803 last quarter. Newmont Mining Corporation now has $20.94 billion valuation. The stock decreased 0.38% or $0.15 during the last trading session, reaching $39.26. About 729,977 shares traded. Newmont Mining Corporation (NYSE:NEM) has declined 1.49% since February 16, 2017 and is downtrending. It has underperformed by 18.19% the S&P500.
Investors sentiment increased to 1.4 in Q3 2017. Its up 0.47, from 0.93 in 2017Q2. It increased, as 35 investors sold NEM shares while 147 reduced holdings. 85 funds opened positions while 169 raised stakes. 427.26 million shares or 26.53% more from 337.68 million shares in 2017Q2 were reported. The California-based Knightsbridge Asset Mgmt Ltd Liability Company has invested 5.44% in Newmont Mining Corporation (NYSE:NEM). Robeco Institutional Asset Bv owns 238,675 shares or 0.06% of their US portfolio. 14,938 were reported by Moors & Cabot. Lmr Prtnrs Llp invested in 0.21% or 51,932 shares. 956,071 are held by California State Teachers Retirement Sys. Calamos Advsrs Ltd Liability Com holds 0.07% of its portfolio in Newmont Mining Corporation (NYSE:NEM) for 231,687 shares. Leonetti And Ltd invested 2.15% of its portfolio in Newmont Mining Corporation (NYSE:NEM). Moreover, Dc Cap Advisors Ltd has 7.43% invested in Newmont Mining Corporation (NYSE:NEM) for 300,000 shares. Axa stated it has 114,180 shares. Regions Finance Corp invested in 0% or 7,764 shares. State Of Tennessee Treasury Department reported 191,981 shares. Janney Montgomery Scott Limited Liability Co stated it has 35,848 shares. Banque Pictet Cie reported 152,988 shares or 0.13% of all its holdings. M&R Cap has invested 0.02% in Newmont Mining Corporation (NYSE:NEM). Ameriprise Financial reported 0.01% of its portfolio in Newmont Mining Corporation (NYSE:NEM).
Cohen & Steers Inc decreased Apple Inc. (NASDAQ:AAPL) stake by 133,390 shares to 79,829 valued at $12.30 million in 2017Q3. It also reduced Blackrock Muniholdings Insur (MFL) stake by 33,133 shares and now owns 94,138 shares. Kilroy Realty Corp. (NYSE:KRC) was reduced too.
Since September 1, 2017, it had 0 insider buys, and 11 insider sales for $1.16 million activity. Palmer Thomas Ronald sold $47,363 worth of Newmont Mining Corporation (NYSE:NEM) on Tuesday, January 2. Lawson Scott P had sold 5,000 shares worth $189,250. 1,000 Newmont Mining Corporation (NYSE:NEM) shares with value of $37,350 were sold by Goldberg Gary J. $392,268 worth of Newmont Mining Corporation (NYSE:NEM) shares were sold by Dorward-King Elaine J. Engel E Randall also sold $229,311 worth of Newmont Mining Corporation (NYSE:NEM) on Thursday, February 1.
Among 24 analysts covering Newmont Mining Corporation (NYSE:NEM), 13 have Buy rating, 0 Sell and 11 Hold. Therefore 54% are positive. Newmont Mining Corporation had 85 analyst reports since July 24, 2015 according to SRatingsIntel. The rating was upgraded by Argus Research on Thursday, July 27 to “Buy”. Scotia Capital maintained the stock with “Buy” rating in Monday, January 15 report. On Tuesday, February 16 the stock rating was initiated by Clarkson Capital with “Buy”. As per Tuesday, September 1, the company rating was upgraded by Scotia Capital. The firm earned “Hold” rating on Friday, July 14 by Jefferies. The rating was downgraded by HSBC on Monday, October 26 to “Hold”. The stock of Newmont Mining Corporation (NYSE:NEM) earned “Sector Perform” rating by RBC Capital Markets on Thursday, January 7. The firm has “Buy” rating by Standpoint Research given on Thursday, December 29. Mackie upgraded the shares of NEM in report on Monday, October 31 to “Buy” rating. On Monday, December 5 the stock rating was downgraded by Citigroup to “Neutral”.
CRISPR Therapeutics AG, a gene editing company, focuses on developing transformative gene medicines for the treatment of serious human diseases using its proprietary clustered, regularly interspaced short palindromic repeats associated protein-9 gene-editing platform in Switzerland. The company has market cap of $1.90 billion. The CRISPR/Cas9 technology allows for changes to genomic DNA. It currently has negative earnings. It has a collaboration agreement with Vertex Pharmaceuticals, Incorporated to develop, manufacture, commercialize, sell, and use therapeutics; a license agreement with Anagenesis Biotechnologies SAS; and a service agreement with MaSTherCell SA to develop and manufacture allogeneic CAR-T therapies.